Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             81 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Acting centrally or peripherally: A renewed interest in the central nervous system penetration of disease-modifying drugs in multiple sclerosis Correale, Jorge

56 C p.
artikel
2 Acute Demyelinating Syndromes: A report of child neurology department of Sfax University Hospital Zouari Mallouli, Salma

56 C p.
artikel
3 Altered adipokine levels are associated with dimethyl fumarate treatment in multiple sclerosis patients Baharnoori, Moogeh

56 C p.
artikel
4 A multidimensional approach to sleep health in multiple sclerosis Whibley, Daniel

56 C p.
artikel
5 An appraisal of antigen identification and IgG effector functions driving host immune responses in multiple sclerosis Yu, Xiaoli

56 C p.
artikel
6 Antigen-specific tolerization in human autoimmunity: Inhibition of interferon-beta1a anti-drug antibodies in multiple sclerosis: A case report Marta, Monica

56 C p.
artikel
7 Application of definitions for conversion to secondary progressive MS in a Danish nationwide population Kopp, Tine Iskov

56 C p.
artikel
8 Assessing the differential sensitivities of wave-CAIPI ViSTa myelin water fraction and magnetization transfer saturation for efficiently quantifying tissue damage in MS Elkady, Ahmed M.

56 C p.
artikel
9 Associations between clinical characteristics and dual task performance in Multiple Sclerosis depend on the cognitive and motor dual tasks used. Veldkamp, R.

56 C p.
artikel
10 Associations between multiple sclerosis and incidence of heart diseases: Systematic review and meta-analysis of observational studies Rapp, Daniel

56 C p.
artikel
11 Cerebrospinal Tau levels as a predictor of early disability in multiple sclerosis Virgilio, Eleonora

56 C p.
artikel
12 Characteristics of secondary progressive multiple sclerosis: Disease activity and provision of care in Germany – A registry-based/multicentric cohort study Frahm, Niklas

56 C p.
artikel
13 Clinical impact of Ocrelizumab extended interval dosing during the COVID-19 pandemic and associations with CD19+ B-cell repopulation Sahi, Nitin Kumar

56 C p.
artikel
14 Clinical predictors of disease progression in a cohort of Tunisian progressive Multiple Sclerosis Souissi, A.

56 C p.
artikel
15 Cognitive Fatigability, not Fatigue predicts employment status in patients with MS three months after rehabilitation Dettmers, Christian

56 C p.
artikel
16 Comorbidity and persistence of disease-modifying therapy use in relapsing remitting multiple sclerosis Parks, Natalie E

56 C p.
artikel
17 Comparing fall detection methods in people with multiple sclerosis: A prospective observational cohort study Hildebrand, Andrea

56 C p.
artikel
18 COVID-19 in Multiple Sclerosis: Clinically reported outcomes from the UK Multiple Sclerosis Register Middleton, RM

56 C p.
artikel
19 Current international trends in the treatment of multiple sclerosis in children—Impact of the COVID-19 pandemic Sandesjö, Fredrik

56 C p.
artikel
20 Deep brain stimulation for multiple sclerosis tremor: A systematic review and meta-analysis Zali, Alireza

56 C p.
artikel
21 Detection of ataxia in low disability MS patients by hybrid convolutional neural networks based on images of plantar pressure distribution Balgetir, Ferhat

56 C p.
artikel
22 Dietary intake and characteristics in persons with multiple sclerosis Venasse, Myriam

56 C p.
artikel
23 Dietary risk factors of primary progressive multiple sclerosis: A population-based case-control study Rezaeimanesh, Nasim

56 C p.
artikel
24 Does the venous pressure theory of multiple sclerosis pathophysiology deserve a second chance? Bateman, Grant Alexander

56 C p.
artikel
25 Dosing schedules for Ofatumumab in multiple sclerosis: Overegging the pudding Avasarala, Jagannadha

56 C p.
artikel
26 Elevated levels of serum CD5 antigen-like protein distinguish secondary progressive multiple sclerosis from other disease subtypes Kamma, Emily

56 C p.
artikel
27 Factors associated with fingolimod rebound: A single center real-life experience Goncuoglu, Cansu

56 C p.
artikel
28 Five-year follow up of the original Irish BICAMS validation cohort Gaughan, Maria

56 C p.
artikel
29 Five-year visual outcomes after optic neuritis in anti-MOG antibody-associated disease Akaishi, Tetsuya

56 C p.
artikel
30 Follow-up after infectious mononucleosis in search of serological similarities with presymptomatic multiple sclerosis Jons, Daniel

56 C p.
artikel
31 Genetically predicted circulating homocysteine, vitamin B12, and folate levels and risk of multiple sclerosis: evidence from a two-sample Mendelian randomization analysis Peng, Haoxin

56 C p.
artikel
32 High titers of myelin oligodendrocyte glycoprotein antibody are only observed close to clinical events in pediatrics Lui, Allysa

56 C p.
artikel
33 Humoral immune response following SARS-CoV-2 mRNA vaccination concomitant to anti-CD20 therapy in multiple sclerosis Novak, Frederik

56 C p.
artikel
34 Impact of COVID-19 public health measures on myelin oligodendrocyte glycoprotein IgG-associated disorders in children Kaseka, Matsanga Leyila

56 C p.
artikel
35 Importance of T-cell response to COVID-19 vaccination in patients with multiple sclerosis treated by anti-CD20 therapies: New vaccines are required to be developed Naser Moghadasi, Abdorreza

56 C p.
artikel
36 Improving smoking cessation support for people with multiple sclerosis: A qualitative analysis of clinicians’ views and current practice Grech, Lisa B

56 C p.
artikel
37 Improving the detection and treatment of depression in Australians with multiple sclerosis: A qualitative analysis Hunter, Assunta

56 C p.
artikel
38 Infection incidence and management in multiple sclerosis patients after initiating disease-modifying therapy Swart, Elizabeth C.S.

56 C p.
artikel
39 In vivo evidence of functional disconnection between brainstem monoaminergic nuclei and brain networks in multiple sclerosis Carandini, Tiziana

56 C p.
artikel
40 Isolated cognitive syndrome is a prodromal presentation of multiple sclerosis Sinay, Vladimiro

56 C p.
artikel
41 It is time to move to alternative clinical trial designs: Reconsidering the holy grail of trial methodology Yeh, E. Ann

56 C p.
artikel
42 MENACTRIMS practice guideline for COVID-19 vaccination in patients with multiple sclerosis Yamout, Bassem I

56 C p.
artikel
43 Meta-analysis of effectiveness of steroid-sparing attack prevention in MOG-IgG-associated disorder Thakolwiboon, Smathorn

56 C p.
artikel
44 Methylphenidate may improve mental fatigue in individuals with multiple sclerosis: A pilot clinical trial Natsheh, J.Y.

56 C p.
artikel
45 MRI but not demographic or clinical characteristics differ between familial and sporadic MS cases Moghadam, Nahid Beladi

56 C p.
artikel
46 Multiple sclerosis in Sri Lanka; epidemiology, demographic patterns and current trends Senanayake, Bimsara

56 C p.
artikel
47 Mutations in the John Cunningham virus VP1 gene could predispose to the development of progressive multifocal leukoencephalopathy in multiple sclerosis patients undergoing treatment with natalizumab Flores, J.

56 C p.
artikel
48 Myelin oligodendrocyte glycoprotein (MOG) antibody-mediated disease: The difficulty of predicting relapses Epstein, Samantha E.

56 C p.
artikel
49 Neuromyelitis optica spectrum disorder (NMOSD) associated with cancer: A systematic review Shahmohammadi, Sareh

56 C p.
artikel
50 Neuromyelitis optica spectrum disorders: A nationwide Portuguese clinical epidemiological study Santos, Ernestina

56 C p.
artikel
51 Optic neuritis in Asian type opticospinal multiple sclerosis (OSMS-ON) in a non-Asian population: A functional-structural paradox Meneguette, Nathalie Stéphanie

56 C p.
artikel
52 Outcomes of COVID-19 among patients treated with subcutaneous interferon beta-1a for multiple sclerosis Freedman, Mark S.

56 C p.
artikel
53 Patient experience and self-perceived biopsychosocial burden of people living with multiple sclerosis: An epidemiological survey (BPS-MuScle study) in Spain Moral-Torres, Ester

56 C p.
artikel
54 Patients’ experiences of self-identification, seeking support, and anticipation of potential relapse in multiple sclerosis Wicks, Charlotte R.

56 C p.
artikel
55 Peripheral nervous system electrodiagnostic abnormalities in predominantly Hispanic Multiple Sclerosis patients Lizarraga, Alexis A

56 C p.
artikel
56 Perturbation practice in multiple sclerosis: Assessing generalization from support surface translations to tether-release tasks Van Liew, Charles

56 C p.
artikel
57 Plasma circulating vitamin C levels and risk of multiple sclerosis: a two-sample Mendelian randomization analysis Peng, Haoxin

56 C p.
artikel
58 Predictors of cognitive fatigue and fatigability in multiple sclerosis Mackay, Leila

56 C p.
artikel
59 ProspeCtive study to evaluate efficacy, safety and tOlerability of dietary supplemeNT of Curcumin (BCM95) in subjects with Active relapsing MultIple Sclerosis treated with subcutaNeous Interferon beta 1a 44 mcg TIW (CONTAIN): A randomized, controlled trial Petracca, Maria

56 C p.
artikel
60 Racial and ethnic disparities in treatment response and tolerability in multiple sclerosis: A comparative study Pérez, Carlos A

56 C p.
artikel
61 Reduced quality of life in a pediatric-onset Neuromyelitis optica spectrum disorders cohort Paolilo, Renata Barbosa

56 C p.
artikel
62 Reinforcing the evidence of oligoclonal bands as a prognostic factor in patients with Multiple sclerosis Ben Noon, G.

56 C p.
artikel
63 Restless legs syndrome in pediatric onset multiple sclerosis Yalcinkaya, Beyza Citci

56 C p.
artikel
64 Restless legs syndrome in people with multiple sclerosis: An updated systematic review and meta-analyses Ozdogar, Asiye Tuba

56 C p.
artikel
65 Retinal microvascular and neuronal function in patients with multiple sclerosis: 2-year follow-up Chen, Qi

56 C p.
artikel
66 Serum GFAP and NfL levels in benign relapsing-remitting multiple sclerosis Niiranen, Marja

56 C p.
artikel
67 Smoking, cardiovascular risk factors and LRP2 gene variation: Associations with disease severity, cognitive function and brain structure in primary progressive multiple sclerosis Chow, Helene Højsgaard

56 C p.
artikel
68 Sociodemographic and clinical characteristics of diet adherence and relationship with diet quality in an international cohort of people with multiple sclerosis Simpson-Yap, Steve

56 C p.
artikel
69 Sociodemographic and clinical factors associated with depression, anxiety, and general mental health in people with multiple sclerosis during the COVID-19 pandemic Uhr, Lauren

56 C p.
artikel
70 The cellular immune response against Epstein-Barr virus decreases during ocrelizumab treatment Pham, H.Phuong T.

56 C p.
artikel
71 The investigation of the cerebral venous system in multiple sclerosis Beggs, Clive

56 C p.
artikel
72 The MuSC-19 study: The Egyptian cohort Zakaria, Magd

56 C p.
artikel
73 The prevalence of Myocardial Infarction among Multiple Sclerosis Patients: a Systematic Review and Meta-analysis Tavallaei, Mohammad Javad

56 C p.
artikel
74 The relationship between plantar sensation and muscle onset during automatic postural responses in people with multiple sclerosis and healthy controls Monaghan, A.S.

56 C p.
artikel
75 The role of expectations and future-oriented cognitions in quality of life of people with multiple sclerosis: A systematic review Maguire, Rebecca

56 C p.
artikel
76 The role of oxidative stress and haematological parameters in relapsing-remitting multiple sclerosis in Kurdish population Rasoul, Abdulrahman Aziz

56 C p.
artikel
77 Treatment of MOG-IgG associated disease in paediatric patients: A systematic review Klein da Costa, Bruna

56 C p.
artikel
78 UK variance in DMT advice and prescribing in MS and pregnancy: Impact of the UK consensus on pregnancy in multiple sclerosis ABN guidelines Yam, Charmaine

56 C p.
artikel
79 Vaccine hesitancy among people with multiple sclerosis Yap, Siew Mei

56 C p.
artikel
80 Vitamin D3 and estradiol alter PAD2 expression and activity levels in C6 glioma cells Ghasempour, Ghasem

56 C p.
artikel
81 Vitamin D status, proinflammatory cytokines and bone mineral density in Mexican people with multiple sclerosis Hernández-Ledesma, Ana Laura

56 C p.
artikel
                             81 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland